|Beta 1,3-Glucan Cancer Research
|Glucan Source: Yeast
Vetvicka, V, Terayama K, Mandeville R, Brousseau P, Kournikakis B, Ostroff
β1,3- glucan prophylactically protects against anthrax infection and cancer in
Journal of the American Nutraceutical Association. Vol. 5, No. 2, Spring
β1,3-glucans from various bacterial, mushroom, yeast, and cereal sources
have been established as immunomodulators. In the present paper we demonstrate that
orally-administered yeast β1,3-glucan had significant effects as a prophylactic treatment
to reduce the mortality of anthrax infection in mice. In addition, the same type of
treatment also inhibited the growth of metastatic cancer cells in vivo. The
mechanism of action involves the stimulation of three important cytokines: IL-2, IFN-γ,
and TNF These results provide preclinical evidence for the beneficial effects
of orally-administered yeast
Tokunaka K, Ohno N, Adachi Y, Tanaka S, Tamura H, Yadomae T.
Immunopharmacological and immunotoxicological activities of a water-soluble
(1-->3)-beta-D-glucan, CSBG from Candida spp.
Int J Immunopharmacol. 2000 May;22(5):383-94. PMID: 10708886 [PubMed - indexed for MEDLINE]
|We have established a convenient, two-step procedure to solubilize the yeast
cell wall (1-- >3)-beta-D-glucan using the combination of NaClO oxidation and DMSO
extraction. Candida soluble beta-D-glucan (CSBG) was mainly composed of a linear beta-1,3
glucan with a linear beta-1,6-glucan moiety. In this study, we screened for several
immunopharmacological activities of CSBG and found the following activities: (1)
interleukin-6 synthesis of macrophages in vitro; (2) antagonistic effect for zymosan
mediated-tumor necrosis factor synthesis of macrophages; (3) augmentation for
lipopolysaccharide mediated tumor necrosis factor and nitrogen oxide syntheses of
macrophages; (4) activation of alternative pathway of complement; (5) hematopoietic response
on cyclophosphamide induced leukopenia; (6) the antitumor effect on ascites form tumor; (7)
Enhanced vascular permeability; (8) priming effect on lipopolysaccharide triggered TNF-alpha
synthesis; and (9) adjuvant effect on antibody production. These results strongly suggested
that CSBG possessed various immunopharmacological activity.
Sveinbjornsson B, Olsen R, Seternes OM, Seljelid R.
Macrophage cytotoxicity against murine meth A sarcoma involves nitric oxide-mediated apoptosis.
Biochem Biophys Res Commun. 1996 Jun 25;223(3):643-9. PMID: 8687449 [PubMed - indexed for MEDLINE]
|We have studied the cytotoxic effect of stimulated macrophages on Meth A tumor
cells in vitro. When stimulated with interferon-gamma and soluble beta-1,3-D-glucan,
macrophages exerted cytotoxicity towards syngeneic Meth A tumor cells. This cytotoxicity was
associated with a high level of nitric oxide production. Both cell death and nitric oxide
production were significantly inhibited by the addition of aminoguanidine, a specific
inhibitor of inducible nitric oxide synthase (iNOS), to the culture medium. The cytotoxic
effect was accompanied by internucleosomal cleavage of DNA as shown by electrophoresis and
DNA fragmentation assay.
|Glucan Source: Fungal
Ohno N, Miura NN, Nakajima M, Yadomae T.
Antitumor 1,3-beta-glucan from cultured fruit body of Sparassis crispa.
Biol Pharm Bull. 2000 Jul;23(7):866-72. PMID: 10919368 [PubMed - indexed for
|Sparassis crispa is an edible mushroom recently cultivable in Japan.
Polysaccharide fractions were prepared from the cultured S. crispa by repeated extraction
with hot water (SCHWE), cold NaOH (SCCA), and then hot NaOH (SCHA). HWE was further separated
by 1 volume (SCHWE1v) or 4 volumes (SCHWE4v) of ethanol-precipitable fractions. By chemical,
enzymic, and NMR analyses, the primary structures of SCHWE1v, SCCA, and SCHA were 6-branched
1,3-beta-glucan, having one branch in approximately every third mainchain unit. All of these
fractions showed antitumor activity to the solid form of Sarcoma 180 in ICR mice with strong
vascular dilation and hemorrhage reaction. These fractions also showed enhanced hematopoietic
response to cyclophosphamide induced leukopenic mice following intraperitoneal or peroral
Mashiba H, Matsunaga K.
Inhibition and augmentation of lymphoma metastasis by adoptively transferred peritoneal
macrophages in hamster.
Cancer Lett. 1986 Oct;33(1):11-8. PMID: 3768859 [PubMed - indexed for
|The effect of adoptively transferred peritoneal exudate cells on the metastasis
of hamster lymphoma was studied. Metastatic spread occurring after the surgical removal of a
primary tumor was considerably inhibited by the adoptive transfer of the peritoneal exudate
cells (PEC) stimulated by immunostimulants, using a streptococcal preparation (OK-432) or a
purified beta (1-3) glucan (SPG). However, the inhibitory effect on metastasis was abrogated
by the in vitro treatment of the peritoneal adherent cells with silica. PEC stimulated with
lymphokines in vitro was also effective in inhibiting metastasis. However, the adoptive
transfer of peritoneal adherent cells treated in vitro with 12-O-tetradecanoylphorbol acetate
(TPA) in vitro, augmented metastatic spread in tumor-bearing hamsters which usually exhibit
concomitant immunity. The relation of the state of the functional activity of macrophages to
metastasis is discussed.
Bobek P, Galbavy S.
Effect of pleuran (beta-glucan from Pleurotus ostreatus) on the antioxidant status of the organism and
on dimethylhydrazine-induced precancerous lesions in rat colon.
Br J Biomed Sci. 2001;58(3):164-8. PMID: 11575739 [PubMed - indexed for
|The effect of pleuran (beta-1,3-D-glucan isolated from the oyster mushroom
Pleurotus ostreatus) on the antioxidant status of the organism and on the development of
precancerous aberrant crypt foci (ACF) lesions in the colon is studied in the male Wistar
rat. A diet containing either 10% pleuran or 10% cellulose was compared with a cellulose-free
diet and both were found to significantly reduced conjugated diene content in erythrocytes
and in liver. Particularly significant was the reduction of conjugated dienes in the colon
following pleuran administration. Diets containing cellulose and pleuran reduced glutathione
peroxidase (GSH-PX) activity and increased catalase activity in erythrocytes. Pleuran
increased superoxide dismutase (SOD) and GSH-PX activity (compared with the cellulose diet),
and glutathione reductase activity (compared with the cellulose-free diet) in liver; and both
diets reduced glutathione levels significantly in the colon. ACF lesions developed in the
colon of all animals fed a cellulose-free diet; however, the incidence was reduced to 64% and
60% following the cellulose and pleuran diets, respectively. The highest average count of the
most frequent small ACF lesions--and highest total count--was seen in animals fed a
cellulose-free diet. Although ACF lesions were reduced by the cellulose diet, the more
significant reduction statistically (>50%) was achieved with the pleuran diet.
Takeyama T, Suzuki I, Ohno N, Oikawa S, Sato K, Ohsawa M, Yadomae T.
Distribution of grifolan NMF-5N (I/B), a chemically modified antitumor beta-glucan in mice.
J Pharmacobiodyn. 1988 Jun;11(6): 381-5. PMID: 3171879 [PubMed - indexed for
|The distribution of a 3H-labeled chemically modified antitumor beta-glucan,
grifolan NMF-5N (I/B), in various tissues after an injection into mice was examined in order
to obtain information on distribution of the parent antitumor beta-glucan, grifolan NMF-5N.
Grifolan NMF-5N was treated with sodium metaperiodate and sodium borotritide to obtain
tritium-labeled grifolan NMF-5N [3H-grifolan (I/B)]. When 3H-grifolan (I/B) was administered
into normal mice by intraperitoneal (i.p.) or intravenous (i.v.) injection, radioactivity was
detected in various mouse tissues. Next, 3H-grifolan (I/B) was injected into tumor-bearing
mice 7 d after the tumor inoculation, which is the most effective administration timing for
the antitumor effect of grifolan NMF-5N. The results indicated a strong radioactivity in
spleens and tumor masses. These results suggested a close relationship between the antitumor
activity and the distribution of grifolan NMF-5N in mice.
Takeyama T, Suzuki I, Ohno N, Oikawa S, Sato K, Ohsawa M, Yadomae T.
Host-mediated antitumor effect of grifolan NMF-5N, a polysaccharide obtained from Grifola frondosa.
J Pharmacobiodyn. 1987 Nov;10(11):644-51. PMID: 3446772 [PubMed - indexed
|The antitumor mechanism of grifolan NMF-5N, a beta-1,3-glucan obtained from
mycelia of Grifola frondosa, was examined. Grifolan NMF-5N did not show direct cytocidal
effect on cultured tumor cells. However, intraperitoneal injection of grifolan NMF-5N
increased the number of peritoneal exudate cells and peritoneal adherent cells which showed
cytostatic activity towards syngeneic tumor cells. In an in vivo assay, the administration of
carrageenan, an inhibitor of macrophage function, reduced the antitumor activity of grifolan
NMF-5N. The delayed-type hypersensitivity reaction was augmented in the grifolan
NMF-5N-administered mice. The administration of NMF-5N augmented the induction of cytotoxic T
cells but the antitumor activity of grifolan NMF-5N was reduced in athymic nu/nu mice. In
addition, the treatment with anti-Thy 1,2 antibody and complement C' of spleen cells taken
from mice which showed regression of tumor due to grifolan NMF-5N, reduced the neutralizing
effect in Winn assay. These results suggested that grifolan NMF-5N shows antitumor activity
via host-mediated mechanisms and both macrophages and T cells play important roles in the
Suzuki I, Takeyama T, Ohno N, Oikawa S, Sato K, Suzuki Y, Yadomae T.
Antitumor effect of polysaccharide grifolan NMF-5N on syngeneic tumor in mice.
J Pharmacobiodyn. 1987 Feb;10(2):72-7. PMID: 3598845 [PubMed - indexed for
|Antitumor activity of grifolan NMF-5N, a beta-1,3-glucan obtained from mycelia
of Grifola frondosa, was examined. Grifolan NMF-5N showed antitumor activities in allogeneic
and syngeneic murine tumor systems. In the allogeneic tumor system, a potent antitumor
activity over 95% was observed against the solid form of sarcoma 180 when grifolan NMF-5N was
injected intraperitoneally (i.p.) at 25-200 micrograms/mouse daily for 10 successive days. In
the syngeneic tumor systems, significant antitumor activities were observed against Meth A
fibrosarcoma and MM 46 carcinoma by injection at 100 micrograms/mouse daily for 5 successive
days, especially i.p. injection at day 7-11, when the tumor cells were inoculated
subcutaneously (s.c.) on day 0. Moreover, when grifolan NMF-5N was injected i.p. every other
week, significant antitumor activity was also observed. In addition, a single treatment with
grifolan NMF-5N at 500 micrograms/mouse showed antitumor activities. Grifolan NMF-5N
exhibited antitumor activities against these two syngeneic tumors by intraveneous (i.v.)
injection. However, a marked inhibitory activity was observed by intratumorous (i.t.)
injection against Meth A fibrosarcoma but not against MM46 carcinoma. These results suggest
that antitumor activities of grifolan NMF-5N in murine syngeneic tumor systems depend on not
only dosage but also injection routes and timing.
Ohno N, Adachi Y, Suzuki I, Oikawa S, Sato K, Ohsawa M, Yadomae
Antitumor activity of a beta-1,3-glucan obtained from liquid
cultured mycelium of Grifola frondosa.
J Pharmacobiodyn. 1986 Oct;9(10): 861-4. PMID: 3820062 [PubMed - indexed for
|The antitumor activity of a branched beta-1,3-glucan "grifolan LE" purified from
liquid cultures of Grifola frondosa (Ohno et al. Chem. Pharm. Bull., 34, 1709-1715 (1986] was
examined on an allogeneic murine tumor system. By intraperitoneal (i.p.) administration
(100-200 micrograms/mouse/d X 5) at days 1 to 9 from the tumor transplantation, grifolan LE
showed marked inhibitory activity on the growth of solid form sarcoma 180 in ICR mice.
Significant activity was also observed in intravenous (i.v.) or intratumoral (i.t.)
administrations. However, the oral (p.o.) administration of grifolan LE was not effective.
I.p. administration of grifolan LE at a dose of 100 micrograms/mouse/d X 5 before the tumor
transplantation showed significant inhibition of tumor growth. I.p. administration of
grifolan LE at day +11 to +19 was also effective. Grifolan LE was not effective on the
ascites form of sarcoma 180. The pretreatment of sarcoma 180 cell with grifolan LE in vitro
did not affect tumor growth. The mice cured from the solid form of sarcoma 180 by
administration of grifolan LE had the ability to reject the same tumor cell. From these
results, it is suggested that the antitumor activity of grifolan LE occurred by modification
of biological responses.
Kunimoto T, Baba H, Nitta K.
Antitumor polysaccharide-induced tumor-regressing factor in the
serum of tumor-bearing mice: purification and characterization.
J Biol Response Mod. 1986 Jun;5(3):225-35. PMID: 3723139 [PubMed - indexed
|Marked tumor-regressing activity was induced in the serum of S180 tumor-bearing
mice by injection of an antitumor polysaccharide, CM-TAK [carboxymethylated beta(1-3)glucan].
Maximal activity was induced 7-14 days after the tumor transplantation and 10-12 h after
CM-TAK treatment. A quantitative assay for the activity was established on the basis of the
initial decrease in the number of the tumor cells within 24 h. The factor with
tumor-regressing activity was purified 10,000-fold by the series of hydroxylapatite
chromatography, ammonium sulfate precipitation, anion-exchange chromatography, gel
filtration, and boronate-mediated affinity chromatography. The molecular weight was estimated
to be 250,000 by gel filtration. The activity was proteinase K sensitive, but relatively
resistant to trypsin. Neuraminidase did not affect the activity. It is believed that the
tumor-regressing factor is different from the tumor necrosis factor.
Borchers AT, Stern JS, Hackman RM, Keen CL, Gershwin ME.
Mushrooms, tumors, and immunity.
Proc Soc Exp Biol Med. 1999 Sep;221(4):281-93. Review. PMID: 10460691
[PubMed - indexed for MEDLINE]
|Medicinal properties have been attributed to mushrooms for thousands of years.
Mushroom extracts are widely sold as nutritional supplements and touted as beneficial for
health. Yet, there has not been a critical review attempting to integrate their nutraceutical
potential with basic science. Relatively few studies are available on the biologic effects of
mushroom consumption, and those have been performed exclusively in murine models. In this
paper, we review existing data on the mechanism of whole mushrooms and isolated mushroom
compounds, in particular (1-->3)-beta-D-glucans, and the means by which they modulate the
immune system and potentially exert tumor-inhibitory effects. We believe that the antitumor
mechanisms of several species of whole mushrooms as well as of polysaccharides isolated from
Lentinus edodes, Schizophyllum commune, Grifola frondosa, and Sclerotinia sclerotiorum are
mediated largely by T cells and macrophages. Despite the structural and functional
similarities of these glucans, they differ in their effectiveness against specific tumors and
in their ability to elicit various cellular responses, particularly cytokine expression and
production. Unfortunately, our data base on the involvement of these important mediators is
still rather limited, as are studies concerning the molecular mechanisms of the interactions
of glucans with their target cells. As long as it remains unclear what receptors are involved
in, and what downstream events are triggered by, the binding of these glucans to their target
cells, it will be difficult to make further progress in understanding not only their
antitumor mechanisms but also their other biological activities.
Abe Y, Asano T, Isono K.
The effect of free radicals from non-parenchymal cells (NPC) of the liver on the development of liver
metastases in rat.
Nippon Geka Gakkai Zasshi. 1993 Oct;94(10):1092-9. Japanese. PMID: 8232183
[PubMed - indexed for MEDLINE]
|Tumor cells (AH130 hepatoma cell originated from rat) were injected
intraportally into Donryu rats to produce liver metastases 21 days later. Phagocyte cells
activity was depressed by the administration of Silica, which significantly increased the
number of surface liver metastases. Phagocyte cells were stimulated by beta 1-3-glucan, which
significantly reduced the number of metastases. And the administration of free radical
scavenger (SOD, Catalase) increased the number of metastases. Non parenchymal cells (NPC) of
the liver play a main role of self defence line for portally liver metastases. Then free
radical from these cells were noticed in this study. NPC were isolated, from pronase perfused
rat liver. O2- production by activated NPC was measured by chemiluminescence with CLA. NPC
activated by beta 1-3-glucan added sera increased the luminescence of CLA, and SOD depressed
the production of chemiluminescence. SOD activity of hepatocytes and tumor cells (AH130) were
measured by NBT methods. Hepatocytes had high potential production of SOD, in contrast AH130
had poor production. These results suggest that free radicals from liver NPC was important
for protecting liver metastases.
Yoshioka Y, Uehara N, Saito H.
Conformation-dependent change in antitumor activity of linear and branched (1----3)-beta-D-glucans
on the basis of conformational elucidation by carbon-13 nuclear
magnetic resonance spectroscopy.
Chem Pharm Bull (Tokyo). 1992 May;40(5):1221-6. PMID: 1394638 [PubMed -
indexed for MEDLINE]
|The antitumor activity of (1----3)-beta-D-glucans was tested in order to clarify
its conformation-dependent response together with conformational elucidation by carbon-13
nuclear magnetic resonance (13C-NMR) spectroscopy. It was shown that the following three
conformations, single chain, single helix and triple helix, are readily distinguished by the
high-resolution solid-state 13C-NMR method. It turned out that preparations of linear
(1----3)-beta-D-glucans of a triple helical conformation were ineffective in the inhibition
of tumor growth. These linear (1----3)-beta-D-glucans were converted to an effective form in
the inhibition of tumor growth when they were lyophilized from dimethyl sulfoxide (DMSO)
solutions as a result of a conformational change from the triple helical to the single chain
forms. They were not effective, however, when assayed in DMSO solution. In contrast, it was
found that a branched (1----3)-beta-D-glucan is effective not only in either saline solutions
of the triple helical sample or the lyophilized sample from DMSO, but also in DMSO solution.
The aforementioned drastic change in antitumor activity was interpreted in terms of resulting
conformational changes as analyzed by the 13C-NMR method.
Shirasugi N, Misaki A.
Isolation, characterization, and antitumor activities of the cell wall polysaccharides from
Biosci Biotechnol Biochem. 1992 Jan;56(1):29-33. PMID: 1368133 [PubMed -
indexed for MEDLINE]
|A cell-wall preparation from the cells of Elsinoe leucospila, which produces
elsinan extracellularly when grown on sucrose or glucose-potato extract medium, was
fractionated systematically. The heteropolysaccharide that was released by treatment with
Actinase E digestion, comprised D-mannose, D-galactose, and D-glucose (molar ratio,
1.5:1.0:0.1). Methylation, mild acid hydrolysis, and 13C-NMR studies suggested that the
polysaccharide contains a backbone of alpha-(1----6)-linked D-mannose residues having two
kinds of side chains, one attached at the O-4 with single or short beta-(1----6)-linked
D-galactofuranosyl residues, and the other attached at O-2 with short side chains, most
probably, of alpha-(1----3)-linked D-mannopyranosyl residues. A moderately branched D-glucan
fraction, obtained from the cold alkali extract, was fractionated to give an antitumor-active
purified beta-(1----3)-glucan having branches of single beta-D-glucosyl groups, one out of
eight D-glucose residues being substituted at the O-6.
Saito H, Yoshioka Y, Uehara N, Aketagawa J, Tanaka S, Shibata Y.
Relationship between conformation and biological response for
(1----3)-beta- D-glucans in the activation of coagulation factor G from
limulus amebocyte lysate and host-mediated antitumor activity.
Demonstration of single-helix conformation as a stimulant.
Carbohydr Res. 1991 Sep 18;217:181-90. PMID: 1797400 [PubMed - indexed for
The relationship between the conformation of (1----3)-beta-D-glucans in gel or
hydrated form and the stimulation of two types of biological responses, namely, activation
of coagulation Factor G from limulus amebocyte lysate (LAL) and host-mediated antitumor
activity was examined. Both types were activated by the single-helical conformation, as
revealed by high-resolution, solid-state 13C-n.m.r. spectroscopy. The potency of activation
of Factor G was increased over 100-fold by treatment with a NaOH solution which leads to a
complete or partial conversion from the triple to the single helix. Such a single-helix
specific response was also demonstrated for the antitumor activity of curdlan, although the
distinction was less pronounced for branched (1----3)-beta-D-glucans. The presence of the
single-helix conformation was observed in schizophyllan gel, even though the triple helix
is the most stable form of branched glucans in aqueous media.
Kunimoto T, Baba H, Nitta K.
Tumor-regressing factor induced by antitumor polysaccharide in the serum of tumor-bearing mice.
Hum Cell. 1990 Jun;3(2):124-30. Japanese. PMID: 2085476 [PubMed - indexed
|A potent tumor-regressing activity was found in the serum of mice with S180
tumor undergoing rapid regression caused by antitumor polysaccharides. Beta (1-3) glucan
including CM-TAK and lentinan and mannoglucan MGA induced such activity. It causes a rapid
decrease in the number of tumor cells accompanied with a marked increase in neutrophiles in
solid tumors. The entity of the activity was named as tumor-regressing factor (TRF) and was
partially purified revealing a proteinaceous nature with an approximate molecular weight of
250,000. The factor was induced in a serum of tumor-bearing mice in various host-tumor
combinations after the tumor growth had been established but only weakly in normal mice. The
sensitivity of tumors to the factor was also dependent on the stage of tumor growth. The
serum of normal mice or tumor-bearing mice without polysaccharide treatment exhibited similar
activity as TRF after definite chromatographic step. The chromatographic behavior of the
revealed activity was closely similar to that of the induced factor. It was postulated that a
TRF-like activity exists in normal serum in a inactivated form being bound by antagonist(s)
and the appropriate chromatography might remove the antagonist resulting in the active form
of the factor. The concept was confirmed by reconstituting the chromatographic fractions, the
revealed activity was again obscured after mixing with a certain fraction.
Morikawa K, Kikuchi Y, Abe S, Yamazaki M, Mizuno D.
Early cellular responses in the peritoneal cavity of mice to antitumor immunomodulators.
Gann. 1984 Apr;75(4):370-8. PMID: 6735035 [PubMed - indexed for
|The early cellular responses to antitumor immunomodulators and conventional
inducers, especially the polymorphonuclear leukocyte (PMN) responses, were examined in the
peritoneal cavity of mice to investigate their effect on primary defense mechanisms.
Immunomodulators were classified into 5 groups in terms of PMN response on the basis of its
duration (declining or persistent) and extent (high or low induction): 1) TAK
(beta-1,3-glucan)-type (high, persistent), 2) lentinan-type (high, declining), 3) yeast
mannan-type (low, declining), 4) LPS (lipopolysaccharide)-type (low, persistent), 5) others
(no effect). Since the general PMN response is of the declining type, the persistence of PMN
with TAK- and LPS-type immunomodulators is a characteristic of the PMN-inducing activity.
With respect to the extent, TAK- and lentinan-type immunomodulators induced larger numbers of
PMN and macrophages than conventional inducers. These results suggest that some types of
immunomodulators have effects on the early host-defense mechanism. From the viewpoint of the
general self-defense mechanism we also compared these PMN responses with those to bacteria
and to tumor inoculation, and the properties of substances inducing high PMN response, i.e.,
those with the quality of "foreignness," are discussed.
|Glucan Source: Lentinan
Intratumoral administration of biological preparations-recommendation for integrative
Gan To Kagaku Ryoho. 2001 Oct;28(11):1515-8. Japanese. PMID: 11707968
[PubMed - indexed for MEDLINE]
|The antitumor effect of biological preparations was examined in a double grafted
tumor system. PSK is a hot water extract of cultured mycelia from Coliolus versicolor. Its
protein content is about 38% and the main glycoside portion of PSK is beta-D-glucan. Lentinan
is purified from fruit bodies of Lentinus edodes and is a beta-1, 3-glucan. Cepharanthin is
an extract from the root of Stephania cepharantha HAYATA, consisting of 4 kinds of
biscoclaurine alkaloids. TAHEEBO tea is a hot water extract of Tabebuia avellanedae, the
active ingredient of which is naphthoquinones. If protein-bound polysaccharides were to be
used in Western medicine, these polysaccharides would be purified, but purified beta-glucan
loses its beneficial effects. Similarly, when raw Cepharanthin is purified to isolate its
active ingredient (an alkaloid cepharanthine), its anti-tumor effect is weakened. Clear IAP
induction was observed in serum of mice treated with extracts of Coliolus versicolor and
Stephania cepharantha. However, IAP induction was not observed in the serum of mice treated
with purified beta-glucan or purified alkaloid. This suggests that macrophages may recognize
extracts but not purified substances. In Western medicine, purified substances with known
chemical structures are recognized as drugs, but overdoses of these drugs are toxic to the
body, thus adverse reactions are always an issue. In Chinese medicine, mixtures containing
several crude drugs are recognized as drugs, whose active ingredients are not identified. In
integrative medicine, drugs are extracts that contain active ingredients with known
structures and functions. We propose a Japanese version of integrative medicine which is
neither Western nor Chinese.
Suzuki M, Kikuchi T, Takatsuki F, Hamuro J.
Curative effects of combination therapy with lentinan and interleukin-2 against established murine
tumors, and the role of CD8-positive T cells.
Cancer Immunol Immunother. 1994 Jan;38(1):1-8. PMID: 8299113 [PubMed -
indexed for MEDLINE]
|The antitumor activity of a combination of an antitumor polysaccharide, lentinan
(a beta 1-3 glucan with beta 1-6 branches), and interleukin-2 (IL-2) was evaluated against
established MBL-2 lymphoma and S908.D2 sarcoma at i.d. sites. Treatment of the
MBL-2-tumor-bearing BDF1 mice with lentinan and IL-2 induced complete regression of tumor in
87.5% of mice treated. In contrast, treatments using either lentinan or IL-2 alone failed to
induce complete regression of tumor, although temporal growth inhibition of tumor was
observed about in half of the mice treated. Improvements of antitumor effects by the
combination of lentinan and IL-2 were also observed in the MBL-2/B6 and S908.D2/B10.D2
systems. Expression of the antitumor effects of lentinan/IL-2 treatments required the intact
T cell compartment, because the effects were not observed when nude mice were used. In the
MBL-2/B6 system, the antitumor action of lentinan/IL-2 treatment was abolished in mice
treated with antibody to CD8 antigen, whereas antibodies to CD4 or NK1.1 were ineffective.
Furthermore, augmented tumor-specific cytotoxic T lymphocyte (CTL) activity was observed in
regional lymph node cells of the mice after lentinan and IL-2 administration. These data
indicate that the antitumor effects of lentinan/IL-2 are mediated by CD8+ CTL but not by CD4+
T cells or NK1.1+ NK/LAK cells, and suggest that this combined therapy may be effective
against even established tumors that are resistant to IL-2 therapy.
Suzuki M, Higuchi S, Taki Y, Taki S, Miwa K, Hamuro J.
Induction of endogenous lymphokine-activated killer activity by combined
administration of lentinan and interleukin 2.
Int J Immunopharmacol. 1990;12(6): 613-23. PMID: 2272726 [PubMed - indexed
|Lymphokine-activated killer activity in vivo (endogenous LAK activity) was found
to be augmented by combined administration of lentinan, a beta (1-3) glucan with beta-1,6
branches, and interleukin 2 (IL-2). In contrast, addition of lentinan during culture in vitro
did not augment LAK activity induced by IL-2. Surface marker analysis of endogenous LAK cells
revealed that endogenous LAK cells induced by a combined administration of lentinan and IL-2
were all NK-type LAK cells, which express asialo-GM1 and lack T3, Thy-1 and Lyt2, whereas LAK
cells generated in vitro were composed of both NK-type LAK and T-type LAK cells, which
express T3 and Thy-1, and lack asialo-GM1. Furthermore, combined administration of lentinan
and IL-2 was found to augment the endogenous LAK activity even in the tumor bearer, and show
a substantial inhibition of tumor growth and a significant increase in survival rate in the
C3H/HeN/MM46 system. Results of the present investigation offer a possible clinical
application of a combination of lentinan and IL-2 for immunotherapy against cancer without
detrimental side effects.
Baba H, Kunimoto T, Nitta K, Sato K, Hashimoto S, Kohno M, Kita Y, Ogawa
Rapid tumor regression and induction of tumor-regressing activity in serum by various
Int J Immunopharmacol. 1986;8(6):569-72. PMID: 3793324 [PubMed - indexed for
|A rapid decrease in the number of tumor cells from S180 tumors was caused by
several antitumor polysaccharides including the beta (1-3)glucans lentinan and TAK-N and a
mannoglucan MGA, but not by those lacking antitumor activity. MGA was demonstrated to induce
potent tumor-regressing activity in the serum of tumor-bearing mice similar to that reported
previously to be induced after an injection of CM-TAK, a carboxymethylated beta (1-3)glucan.
It is probable that the induction of rapid regression of established tumors is a phenomenon
common to antitumor polysaccharides and some microbiological products and that the
tumor-regressing factor in the serum underlies a common mechanism.
Herlyn D, Kaneko Y, Powe J, Aoki T, Koprowski H.
Monoclonal antibody-dependent murine macrophage-mediated cytotoxicity against human tumors
is stimulated by lentinan.
Jpn J Cancer Res. 1985 Jan;76(1):37-42. PMID: 3918909 [PubMed - indexed for
|The beta (1----3) glucan lentinan was tested for its capacity to increase the
cytotoxic effect of murine peritoneal macrophages for human tumor cells in the presence of
monoclonal antibodies (MAbs). Activity was maximum in macrophages obtained on day 5 following
intraperitoneal injection of CBA mice with 2.5 mg of lentinan per kg body weight. Macrophages
stimulated by lentinan were cytotoxic in conjunction with IgG1, IgG2a and IgG3 MAbs, but not
with IgG2b, IgM, or IgA MAbs. The demonstration of a similar enhancing effect by lentinan on
human macrophages might have implications for potentiating the tumoricidal effect of these
macrophages in the presence of tumor antigen-specific MAbs.
|Glucan Source: Laminarin Sulfate
Miao HQ, Elkin M, Aingorn E, Ishai-Michaeli R, Stein CA, Vlodavsky I.
Inhibition of heparanase activity and tumor metastasis by laminarin sulfate and synthetic
Int J Cancer. 1999 Oct 29;83(3):424-31. PMID: 10495437 [PubMed - indexed for
|Heparanase activity correlates with the metastatic potential of tumor cells.
Moreover, the anti-metastatic effect of non-anti-coagulant species of heparin and certain
sulfated polysaccharides was attributed to their heparanase-inhibiting activity. We
investigated the effect of a chemically sulfated polysaccharide (laminarin), consisting
primarily of beta-1,3 glucan (sodium laminarin), and of synthetic phosphorothioate
oligodeoxynucleotides, primarily phosphorothioate homopolymer of cytidine (SdC28), on
heparanase activity and tumor metastasis. Investigation of the ability of tumor cells to
degrade heparan sulfate in intact extracellular matrix revealed that heparanase activity
expressed by B16-BL6 mouse melanoma cells and 13762 MAT rat mammary adenocarcinoma cells was
effectively inhibited by LS (50% inhibition at 0.2-1 microgram/ml), but there was no
inhibition by sodium laminarin up to a concentration of 50 microgram/ml. Complete inhibition
of the melanoma heparanase was obtained in the presence of 0.1 microM SdC28. A single i.p.
injection of laminarin sulfate, but not of sodium laminarin, before i.v. inoculation of the
melanoma or breast-carcinoma cells inhibited the extent of lung colonization by the tumor
cells by 80 to 90%. Similar inhibition was exerted by 0.1 microM SdC28. At the effective
concentrations, both compounds had a small effect on proliferation of the tumor cells and on
growth of the primary tumors in vivo. These results further emphasize the involvement of
heparanase in tumor metastasis and the potential clinical application of diverse
heparanase-inhibiting molecules such as sulfated polysaccharides and synthetic polyanionic
molecules. Copyright 1999 Wiley-Liss, Inc.
|Glucan Source: Glucan beads
Seljelid R, Bogwald J, Rasmussen LT, Larm O, Hoffman J, Berge A, Ugelstad
In vivo activation of mouse macrophages with beta-1,3-D-glucan-derivatized plastic beads.
Scand J Immunol. 1985 Jun;21(6):601-5. PMID: 4023630 [PubMed - indexed for
Macrophages obtained from animals treated with beta-1,3-D-glucan-derivatized
plastic beads were greatly stimulated, as judged by morphology, esterase release, and
cytostatic effect on L-929 tumour cells in vitro. The pretreatment of mice with such beads
conferred an apparent absolute local resistance to an otherwise lethal pneumococcal
infection but had no effect on the growth of intraperitoneal AA ascites sarcoma. Moreover,
peritoneal cells from animals pretreated with glucan beads did not protect the animals in a
|Glucan Source: Fungus Sclerotinia Sclerotiorum (SSG)
Suda M, Ohno N, Adachi Y, Yadomae T.
Relationship between the tissue distribution and antitumor activity of highly branched
Biol Pharm Bull. 1994 Jan;17(1):131-5. PMID: 8148801 [PubMed - indexed for
|Distribution of 3H-labeled (1-->3)-beta-D-glucan([3H]SSG) obtained from the
culture filtrate of Sclerotinia sclerotiorum IFO 9395, in various tissues in tumor-bearing
mice was examined. [3H]SSG administered intra-peritoneally was mainly detected in liver,
spleen, kidney and tumor masses. In contrast to i.p. administration, intra-lesionally
administered [3H]SSG was not released from the tumor. Similarly, in a double grafted tumor
system, [3H]SSG was located in the administered tumor and not distributed in the distant site
tumor, in spite of the fact that significant antitumor effect was shown in both tumor sites
in this system. Winn assay confirmed the activation of the systemic antitumor immunity. These
results suggested that the distribution of glucans would be one important factor in
determining their antitumor effects. However, this would not always be necessary if systemic
immunity could be induced.
Sakurai T, Ohno N, Suzuki I, Yadomae T.
Effect of soluble fungal(1-->3)-beta-D-glucan obtained from Sclerotinia
sclerotiorum on alveolar macrophage activation.
Immunopharmacology. 1995 Aug;30(2):157-66. PMID: 8530257 [PubMed - indexed
|In this study, we examined the effect of systemic administration of SSG, a
soluble highly branched (1-->3)-beta-D-glucan obtained from a fungus Sclerotinia
sclerotiorum IFO 9395, on pulmonary immune responses in mice. SSG (10 mg/kg) administered
intravenously (i.v.) rapidly leaked into the alveolar space and enhanced several functions of
alveolar macrophages (AMs), such as phagocytic activity, lysosomal enzyme activity, active
oxygen secretion and cytokine production, on day 1 post-administration. However, kinetic
changes of influx of SSG into alveoli and AM activation after SSG treatment were different.
The enhanced AM functions decreased to control value on day 2 when SSG still existed at the
alveolar space. Additionally, a high dose (500 micrograms/ml) of SSG was needed to activate
AMs in vitro. These data imply that the stimulation by SSG alone is not effective on AM
activation. SSG administered i.v. also augmented interferon gamma (IFN gamma) mRNA expression
in the lung tissue, and the kinetic change of the expression was similar to that of AM
activation. Additionally, a synergistic effect of SSG and IFN gamma was observed on AM
activation in vitro. It may be possible that IFN gamma produced by pulmonary T cells is one
of the important factors for AM activation in vivo by SSG injection. Furthermore, SSG
administered i.v. enhanced candidacidal activity and cytolytic activity against pulmonary
metastatic Lewis lung carcinoma (3LL) cells of AMs, and inhibited significantly the
experimental pulmonary metastasis of 3LL cells. These observations are very useful for the
clinical application of SSG as a biological response modifier (BRM).
Suda M, Ohno N, Adachi Y, Yadomae T.
Modulation of the antitumor effect and tissue distribution of highly branched (1-->3)-beta-D-glucan,
SSG, by carrageenan.
Biol Pharm Bull. 1995 May;18(5):772-5. PMID: 7492998 [PubMed - indexed for
|The action of carrageenan (CAR), a representative blocking reagent for
phagocytes, on the antitumor effect and tissue distribution of highly branched
(1-->3-beta-D-glucan, SSG, was examined. CAR inhibited the antitumor effect of
intraperitoneally administered SSG only when applied before inoculation of the tumor, and had
little effect when applied after tumor inoculation. A similar result was observed when SSG
was administered intralesionally. In contrast, CAR had considerable effect on tissue
distribution of i.p. SSG. The differences with respect to the results in normal mice were: 1)
the distribution of SSG from the peritoneal cavity to the rest of the body was inhibited, 2)
large numbers of peritoneal exudate cells (PEC) were produced and a relatively high
concentration of 3H-SSG was found in the PEC fraction 48h after administration of 3H-SSG, 3)
one week after administration, 3H-SSG was distributed to throughout the body but the amount
of 3H-SSG distributed was lower than in normal mice, 4) a significant amount of 3H-SSG was
recovered from ligaments (containing omental milky spots, peritoneum, mesentery and
associated fat) in which negligible amounts were found in normal mice. The results suggest
that the inhibition of the antitumor effect of SSG by CAR probably results from the
prevention of the natural resistance of mice which is related to phagocytic function, and
that the distribution of SSG to throughout the body is significantly modulated by
Suzuki I, Hashimoto K, Ohno N, Tanaka H, Yadomae T.
Immunomodulation by orally administered beta-glucan in mice.
Int J Immunopharmacol. 1989;11(7): 761-9. PMID: 2599714 [PubMed - indexed
|Orally administered SSG, a beta-1,3-glucan obtained from the culture filtrate of
the fungus Sclerotinia sclerotiorum IFO 9395, was examined for effects on immune responses in
mice. The proliferative responses of spleen cells from SSG-administered mice (40 or 80 mg/kg,
daily for 5 or 10 consecutive days) to a T-cell mitogen, concanavalin A (Con A), or a B-cell
mitogen, lipopolysaccharide (LPS), were higher than those from normal mice. Oral
administration of SSG (80 mg/kg) to mice also enhanced the activities of both natural killer
(NK) cells in spleen and the lysosomal enzyme of peritoneal macrophages. Furthermore,
significant inhibition of tumor growth was observed in syngeneic tumor systems when SSG was
administered directly after tumor implantation. The inhibiting effect required high doses of
SSG (over 80 mg/kg). These results demonstrate that SSG can potentiate the immune response of
mice following oral administration.
Suzuki I, Hashimoto K, Yadomae T.
The effects of a highly branched beta-1,3-glucan, SSG, obtained
from Sclerotinia sclerotiorum IFO 9395 on the growth of syngeneic
tumors in mice.
J Pharmacobiodyn. 1988 Aug;11(8): 527-32. PMID: 3236210 [PubMed - indexed
|The effects of a highly branched beta-1,3-glucan, SSG, obtained from a culture
filtrate of a fungus, Sclerotinia sclerotiorum IFO 9395, on the growth of syngeneic tumors
and antitumor effector cells were examined. In the Meth A solid tumor systems, SSG
administered intraperitoneally (i.p.), intralesionally (i.l.), or intravenously (i.v.) showed
significant antitumor activities.Furthermore, SSG administered i.p. also showed effective
activities against IMC carcinoma. SSG enhanced nonspecific antitumor effector functions, such
as natural killer activity of spleen cells and the cytolytic activity of peritoneal
macrophages. Additionally, SSG increased the specific immune response (cytotoxic T lymphocyte
activity) against allogeneic tumor cells.
Ohno N, Kurachi K, Yadomae T.
Antitumor activity of a highly branched (1----3)-beta-D-glucan, SSG, obtained from
Sclerotinia sclerotiorum IFO 9395.
J Pharmacobiodyn. 1987 Sep;10(9): 478-86. PMID: 3437391 [PubMed - indexed
|The antitumor activity of a highly branched (1----3)-beta-D-glucan, SSG,
purified from the liquid culture filtrate of Sclerotinia sclerotiorum IFO 9395 and its
several derivatives were treated in ICR mice bearing Sarcoma 180 cells. SSG was effective by
both systemic (intraperitoneal and intravenous) and local (intratumoral) administrations on
the solid form of Sarcoma 180 in ICR mice and the mice acquired resistance to subsequent
inoculation of Sarcoma 180. However, SSG was not effective on the ascites form Sarcoma 180.
The pretreatment of ICR mice with carrageenan suppressed the antitumor activity, suggesting
the involvement of macrophages on the antitumor activity. Derivatives prepared from SSG by
periodate oxidation/borohydride reduction showed antitumor activity, but those obtained after
acetylation, carboxymethylation and hydroxyethylation were less active. From these results,
it is suggested that SSG is a useful antitumor glucan which modifies biological responses and
can be used as a source for some antitumor derivatives.
|Glucan Source: Bacterial
Kasai S, Fujimoto S, Nitta K, Baba H, Kunimoto T.
Antitumor activity of polymorphonuclear leukocytes activated by a beta-1,3-D-glucan.
J Pharmacobiodyn. 1991 Sep;14(9): 519-25. PMID: 1779406 [PubMed - indexed
|The antitumor activity of mouse polymorphonuclear leukocyte (PMN) treated with a
beta-1,3- D-glucan from Alcaligenes faecalis var. myxogenes IFO 13140 (TAK-N) and its
carboxymethylated derivative (CM-TAK) was investigated in vitro and in vivo. ICR mouse PMN
showed strong cytotoxicity against sarcoma 180 cells and inhibition of the growth of the
tumor cells in vitro in the presence of TAK-N but not in the presence of CM-TAK. Since the
cytotoxicity induced by TAK-N was almost completely inhibited by catalase, it seems to be
mediated by H2O2 production by PMN. On the other hand, TAK-N induced no cytotoxicity in
macrophages and neither did CM-TAK in PMN or in macrophage. Intraperitoneal injection of
TAK-N into ICR mice induced a large number of PMN and macrophages in the peritoneal cavity.
The peritoneal exudate PMN which were harvested at 10 to 72 h after TAK-N injection showed
cytotoxicity against sarcoma 180 cells, but the peritoneal exudate macrophages did not.
Treatment of sarcoma 180 ascites tumor-bearing ICR mice with TAK-N at a dose of 100 mg/kg
prolonged significantly the survival time over that of the control. These results indicate
that TAK-N induces PMN cytotoxicity against sarcoma 180 cells not only in vitro but also in
vivo. The antitumor effect of TAK-N on sarcoma 180 ascites tumor seems to be derived
from PMN stimulated with TAK-N.
Araki A, Inoue T, Kimura S, Fukase S, Sendo F.
Enhancement of polymorphonuclear leukocyte-mediated tumor cytotoxicity by serum factor(s).
Jpn J Cancer Res. 1990 Jan;81(1):69-78. PMID: 2108949 [PubMed - indexed for
|It has been reported that beta-1,3-D-glucan isolated from Alcaligenes faecalis
(TAK) promoted tumor cytolysis by mouse polymorphonuclear leukocytes (PMN). We investigated
the effect of serum on mouse PMN tumor cytolysis induced by TAK and other PMN stimulators.
Addition of fetal calf serum (FCS) to the cytolysis assay enhanced tumor cytolysis by PMN in
a dose-dependent manner. Sera obtained from horses, mice, and rats were also effective
enhancers of PMN tumor cytolysis. When FCS was added after the assay was under way, the
enhancing effect decreased proportionally to the time elapsed. The enhancing activity was
detected over a broad range of fractions with a peak at 170 kD by fractionation on a Superose
6 column. The responsible factor(s) in serum was stable after treatment at 60 degrees C, 30
min or after lowering the pH to 2. Mouse PMN stimulated with TAK increased production of
hydrogen peroxide in the presence of FCS.
Fukase S, Inoue T, Arai S, Sendo F.
Tumor cytotoxicity of polymorphonuclear leukocytes in beige mice: linkage of high
responsiveness to linear beta-1,3-D-glucan with the beige gene.
Cancer Res. 1987 Sep 15;47(18):4842-7. PMID: 3621179 [PubMed - indexed for
|Beige mice (bg/bg) have many functional defects in their leukocytes and these
phenotypes are inherited autosomal recessively. We studied the tumor cytotoxicity of
polymorphonuclear leukocytes (PMN) obtained from bg/bg. The intensity of tumor cytotoxicity
of PMN induced by linear beta-1,3-D-glucan was significantly higher in bg/bg PMN than in PMN
of heterozygous control mice (bg/+). To analyze this phenomenon more precisely from the
genetic viewpoint, we determined the tumor cytotoxicity of PMN from mice obtained by several
mating experiments. (a) The intensity of linear beta-1,3-D-glucan-induced PMN cytotoxicity
was found to be genetically defined and linked completely with the beige gene. In litter
mates obtained from bg/+(female) X bg/bg(male), bg/bg(female) X bg/+(male), and bg/+(female)
X bg/+(male) mating, PMN from only bg/bg showed significantly higher tumor cytotoxicity than
those from bg/+ or mice that do not possess the beige gene (+/+). (b) The tumor cytotoxicity
induced by other stimulants (phorbol myristate acetate and cytokines) was not significantly
higher in bg/bg than bg/+ or +/+ PMN. It was concluded that the high responsiveness to linear
beta-1,3-D-glucan in terms of tumor cytotoxicity of PMN was determined by the locus that is
linked to the beige gene and is expressed autosomal recessively.
Morikawa K, Kamegaya S, Yamazaki M, Mizuno D.
Hydrogen peroxide as a tumoricidal mediator of murine polymorphonuclear leukocytes induced by
a linear beta-1,3-D-glucan and some other immunomodulators.
Cancer Res. 1985 Aug;45(8):3482-6. PMID: 2990672 [PubMed - indexed for
|Polymorphonuclear leukocytes (PMN) of mice can destroy tumor cells effectively
in vitro in the presence of antitumor polysaccharide, linear beta-1, 3-D-glucan from
Alcaligenes faecalis var. myxogenes IFO 13140 (TAK), and some other immunomodulators. In the
present study, we investigated the mechanism of the tumoricidal activity of PMN induced by
these immunomodulators and especially TAK. The TAK-induced PMN cytotoxicity was concluded to
involve hydrogen peroxide from the following results: (a) the cytotoxicity depended on
glucose consumption; (b) it was almost completely inhibited by catalase but not affected by
superoxide dismutase; (c) it was not reduced by cyanide or azide, which are inhibitors of
myeloperoxidase; (d) it was not affected by scavengers of singlet oxygen or hydroxyl radical;
(e) release of hydrogen peroxide from PMN was observed by the addition of TAK; (f) MM46
target cells were lysed directly by hydrogen peroxide in the absence of myeloperoxidase; (g)
the supernatant of PMN in the presence of TAK, tested as a stable cytotoxic factor, did not
have cytotoxic activity, and protease inhibitors had no effect on this cytotoxicity. These
results suggest that hydrogen peroxide is a direct cytotoxic mediator in TAK-induced PMN
cytotoxicity. Next, the mechanism of PMN cytotoxicities induced by other immunomodulators was
also examined and was compared with that induced by TAK. The results suggest that hydrogen
peroxide is also important for these cytotoxicities whereas, unlike the results with TAK, the
H2O2:halide:myeloperoxidase system may partly participate in the cytotoxicities with some
|Glucan Source: Aminated Glucan
Sveinbjornsson B, Rushfeldt C, Seljelid R, Smedsrod B.
Inhibition of establishment and growth of mouse liver metastases after treatment with interferon
gamma and beta-1,3-D-glucan.
Hepatology. 1998 May;27(5):1241-8. PMID: 9581677 [PubMed - indexed for
|The purpose of this study was to investigate the combined antitumor effect of
aminated beta-1,3-D-glucan (AG) and interferon-gamma (IFN-gamma) in an experimental liver
metastasis model. Liver metastases were established by inoculation of C-26 colon carcinoma
cells into the superior mesenteric vein of syngeneic mice. Treatment of mice started 24 hours
after inoculation of tumor cells by daily intravenous injections of either AG, IFN-gamma, or
a combination of both for a duration of 6 days. The resultant liver metastases were then
quantified after an additional period of 11 days. Combination of IFN-gamma and AG inhibited
the growth of liver metastases almost entirely. IFN-gamma was also very efficient, while AG
alone did not exert any significant antitumor effect. These results, along with histological
studies from mice receiving AG and IFN-gamma, indicated that activation and recruitment of
liver macrophages may be a part of the mechanism responsible for the inhibition of metastatic
growth observed in this study.
Seljelid R, Figenschau Y, Bogwald J, Rasmussen LT, Austgulen R.
Evidence that tumor necrosis induced by aminated beta 1-3D polyglucose is mediated by a concerted
action of local and systemic cytokines.
Scand J Immunol. 1989 Dec;30(6): 687-94. PMID: 2532395 [PubMed - indexed for
|Aminated beta 1-3D polyglucose (AG) causes regression of Meth A sarcoma in
syngeneic mice when injected systemically on day 7 after tumour inoculation. AG does not
concentrate in the tumour, but distributes throughout the body. AG treatment causes release
of large amounts of interleukin 1 (IL-1) both in vivo and in macrophage cultures in vitro. AG
is a weak stimulus for tumour necrosis factor (TNF) release both in vitro and in vivo.
However, tumour tissue and sera from untreated mice on days 3 and 7 after inoculation contain
significant amounts of TNF, whereas tumour tissue and sera on day 14 contain insignificant
amounts of TNF. This correlates exactly with the sensitivity to AG treatment. IL-1, and TNF
when injected locally cause reduction in tumour blood circulation and also shrinkage of the
tumour. All these facts taken together indicate that the tumour circulatory failure and
necrosis induced by AG are mediated by local TNF-unrelated to the treatment--potentiated by
systemic cytokines triggered by the AG.
A water-soluble aminated beta 1-3D-glucan derivative causes regression of solid tumors in mice.
Biosci Rep. 1986 Sep;6(9):845-51. PMID: 3814772 [PubMed - indexed for
|Meth A sarcoma, when inoculated in the skin, grew progressively in hybrid CB6
F1(Balb/c X C57B1/6) mice. When water-soluble aminated beta 1-3D-glucan (AG) was injected
intravenously or intraperitoneally on day 7 of tumor growth, the tumors underwent complete
regression. When the injection was performed on day 3 there was regression of tumors in only
about half of the cases. When the injection was performed on day 14 there was no apparent
effect on tumor growth. Tumors in thymectonized animals did not appear to respond to
treatment with AG on day 7. The relatively simple chemistry and low toxicity of AG, together
with its solubility in biological fluids, makes it a promising tool in experimental-- and
possibly clinical--tumor therapy.
Seljelid R, Bogwald J, Hoffman J, Larm O.
A soluble beta-1,3-D-glucan derivative potentiates the cytostatic and cytolytic capacity of mouse
peritoneal macrophages in vitro.
Immunopharmacology. 1984 Feb;7(1):69-73. PMID: 6715145 [PubMed - indexed for
|An aminated beta-1,3-D-glucan derivative of curdlan is reported to render
macrophages cytostatic to L-929 cells and to potentiate macrophage cytotoxicity to the tumor
cells in vitro.